![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 26673-26680, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pharmacology, University of Minnesota
Medical School, Minneapolis, Minnesota 55455
A yeast two-hybrid screen identified the
regulatory subunit of the calcium-dependent protease
calpain as a putative DNA ligase III-binding protein. Calpain binds to
the N-terminal region of DNA ligase III, which contains an acidic
proline, aspartate, serine, and threonine (PEST) domain frequently
present in proteins cleaved by calpain. Recombinant DNA ligase III was
a substrate for calpain degradation in vitro. This
calpain-mediated proteolysis was calcium-dependent and was
blocked by the specific calpain inhibitor calpeptin. Western blot
analysis revealed that DNA ligase III was degraded in human fibrosarcoma HT1080 cells following exposure to
DNA Ligase III Is Degraded by Calpain during Cell Death Induced
by DNA-damaging Agents*
and
-radiation. The degradation of DNA ligase III was prevented by pretreatment with calpeptin, which protected irradiated cells from death. Calpeptin treatment also blocked 9-amino camptothecin-induced DNA ligase III
proteolysis and simultaneously protected the cells from death. HT1080
clones expressing a modified DNA ligase III that lacked a recognizable
PEST domain were significantly more resistant to killing by
-radiation or 9- amino camptothecin than were cells that
overexpressed the wild-type form of DNA ligase III. These data show
that calpain-mediated proteolysis of DNA ligase III plays an essential
role in DNA damage-induced cell death in human cells.
*
This work was supported in part by National Institutes of
Health Grants CA61906 and AG16678 and the American Heart Association.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by American Heart Association Northland Affiliate
Predoctoral Fellowship 9951198Z.
§
To whom correspondence should be addressed: Dept. of Pharmacology,
University of Minnesota Medical School, 6-120 Jackson Hall, 321 Church
St., SE, Minneapolis, MN 55455. Tel.: 612-625-8986; Fax: 612-625-8408;
E-mail: campb034@umn.edu.
This article has been cited by other articles:
![]() |
S. Hata, N. Doi, F. Kitamura, and H. Sorimachi Stomach-specific Calpain, nCL-2/Calpain 8, Is Active without Calpain Regulatory Subunit and Oligomerizes through C2-like Domains J. Biol. Chem., September 21, 2007; 282(38): 27847 - 27856. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Radivojac, L. M. Iakoucheva, C. J. Oldfield, Z. Obradovic, V. N. Uversky, and A. K. Dunker Intrinsic Disorder and Functional Proteomics Biophys. J., March 1, 2007; 92(5): 1439 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hata, S. Koyama, H. Kawahara, N. Doi, T. Maeda, N. Toyama-Sorimachi, K. Abe, K. Suzuki, and H. Sorimachi Stomach-specific Calpain, nCL-2, Localizes in Mucus Cells and Proteolyzes the beta-Subunit of Coatomer Complex, beta-COP J. Biol. Chem., April 21, 2006; 281(16): 11214 - 11224. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Y. Ho and M. S. Satoh Repair of single-strand DNA interruptions by redundant pathways and its implication in cellular sensitivity to DNA-damaging agents Nucleic Acids Res., December 1, 2003; 31(23): 7032 - 7040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, J. K. Barry, Z. Min, G. Tordsen, A. G. Rao, and O.-A. Olsen The Calpain Domain of the Maize DEK1 Protein Contains the Conserved Catalytic Triad and Functions as a Cysteine Proteinase J. Biol. Chem., September 5, 2003; 278(36): 34467 - 34474. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |